Related Experiment Videos

[Infectious toxic hypotension--effect and dosage of midodrine (author's transl)]

Padiatrie Und Padologie
|January 1, 1979
PubMed

Insights

Midodrine, a new oral alpha-sympathicomimetic drug, effectively treats hypotension in children with infectious diseases. Studies show it increases blood pressure and decreases heart rate, proving beneficial in pediatric care.

Area of Science:

  • Pharmacology
  • Pediatrics
  • Internal Medicine

Background:

  • Hypotension is a common complication in pediatric infectious diseases.
  • Alpha-sympathicomimetic drugs are used to manage low blood pressure.
  • Midodrine is a novel oral sympathicomimetic agent.

Purpose of the Study:

  • To evaluate the efficacy of midodrine in treating hypotension in children.
  • To compare the therapeutic effects of midodrine with etilefrine.
  • To assess the safety and effectiveness of midodrine in pediatric patients with infectious conditions.

Main Methods:

  • A randomized study involving 120 children diagnosed with pneumonia, enteritis, or meningitis.
  • Administration of midodrine at an effective oral dosage of 0.06 mg/kg/dosi.
  • Comparison of hemodynamic parameters (blood pressure, heart rate) between midodrine and etilefrine treatment groups.

Main Results:

  • Midodrine demonstrated a statistically significant increase in blood pressure on the first day of treatment.
  • A significant decrease in heart rate was observed in children treated with midodrine.
  • The drug showed comparable or superior therapeutic effects to etilefrine.

Conclusions:

  • Midodrine is a qualified therapeutic option for managing hypotension in pediatric infectious diseases.
  • The drug offers a safe and effective treatment for low blood pressure in infants and children.
  • Early administration of midodrine leads to rapid and significant improvements in hemodynamic stability.

Related Concept Videos